This section showcases the impactful projects in which the NCD Policy Lab is implicated. Through a strategic blend of research, advocacy, and long-term collaboration with our partners, the projects target key issues on improving access to medicines and technologies for NCDs. Explore the featured projects below to discover how the NCD Policy Lab is implicated in shaping and drive positive change towards the adoption of evidence-based policies for improving access to NCD care, medicines, and technologies.
Projects
To mark World Diabetes Day on 14 November 2023, The Lancet Diabetes & Endocrinology is launching an initiative to stimulate research into inequalities in access to treatment for type 1 diabetes. The Commission has as its aim to provide the global health community, national policy makers, local diabetes key opinion leaders and clinicians, diabetes associations and advocates, as well as funders, with a clear road map for the future related to Type 1 Diabetes.
Despite a century of lessons learned in the provision of type 1 diabetes care, a more comprehensive and person centred global plan is still needed to address both the societal and health system needs for people with type 1 diabetes across different life periods, to address existing and future inequities, and to ensure that innovation continues to improve the lives of people with type 1 diabetes globally.
Access to insulin remains highly unequal
This approach needs to provide the global health community, national policy makers, local diabetes key opinion leaders and clinicians, diabetes associations and advocates, as well as funders, a clear road map for the future. With this in mind, a Commission on type 1 diabetes was launched.
About: Explore our Chronic Disease Toolbox, a hub of resources to improve the management of non-communicable diseases in low-and middle income countries. It allows, for example, healthcare professionals, people living with a chronic disease, relatives and caregivers, to freely access academic, clinical and informative resources developed by the Division of Tropical & Humanitarian Medicine (at the Geneva University Hospitals & University of Geneva).
DIAMOND2-Action is a collaborative network which aims to promote and provide tools, data and knowledge on the epidemiology, health system use, access to insulin, and health in type 1 diabetes.
DIAMOND2 is a partnership that, based on collaborative network activities, will:
- Promote epidemiological, public health, health utilization and health economics research in type 1 diabetes.
- Support capacity-building for epidemiological, public health and multi-disciplinary health services research.
- Provide relevant information for communication with decision-makers to support prioritization and policymaking concerning the diagnosis, monitoring, and management of type 1 diabetes globally and locally.
- Supply key epidemiological and healthcare data for patient organizations and people with type 1 diabetes.